Skip to content
177177177

Drawing based on the label description. No photo yet.

“Tablets: 40 mg, blue, oval shaped, film-coated, debossed with "177" on one side and plain on the other side”

177 pill

Pill with imprint 177 is blue, oval, 13 mm and has been identified as Belzutifan 40 mg. It is supplied by Merck Sharp & Dohme LLC.

Belzutifan 40 mg

Imprint
177
Strength
40 mg
Color
Blue
Shape
Oval
Size
13 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Merck Sharp & Dohme LLC
Drug class
Hypoxia-inducible factor inhibitor
NDC
0006-5331, 0006-5331-01, 0006-5331-58, 0006-5331-59

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Belzutifan pills and guides

What is Belzutifan used for?

Belzutifan is a hypoxia-inducible factor inhibitor.

Medicine type
Hypoxia-inducible factor inhibitor
Official uses from the US prescribing label

von Hippel-Lindau (VHL) disease

WELIREG is indicated for treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery.

Renal Cell Carcinoma with a Clear Cell Component (ccRCC)

  • WELIREG, in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph, is indicated for the adjuvant treatment of adult patients with ccRCC at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.
  • WELIREG is indicated for the treatment of adult patients with advanced ccRCC following a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and a vascular endothelial growth factor tyrosine kinase inhibitor (VEGF-TKI).

Pheochromocytoma or Paraganglioma (PPGL)

WELIREG is indicated for the treatment of adult and pediatric patients 12 years and older with locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma (PPGL).

From the FDA-approved label on DailyMed (published Jun 29, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 177 and the other side is plain.
  • It is blue, oval, 13 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Welireg.

Ingredients

Active: Belzutifan

Inactive: Croscarmellose Sodium, Hypromellose Acetate Succinate 06081224 (3 Mpa.s), Magnesium Stearate, Mannitol, Microcrystalline Cellulose, Silicon Dioxide, Fd&c Blue No. 2 Aluminum Lake, Polyethylene Glycol, Unspecified, Polyvinyl Alcohol, Unspecified, Talc, Titanium Dioxide

Other pills with imprint 177

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Belzutifan pills